100 related articles for article (PubMed ID: 10579680)
1. Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions.
Lundberg BB; Griffiths G; Hansen HJ
J Pharm Pharmacol; 1999 Oct; 51(10):1099-105. PubMed ID: 10579680
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin.
Lundberg BB; Griffiths G; Hansen HJ
Int J Pharm; 2000 Sep; 205(1-2):101-8. PubMed ID: 11000546
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.
Losman MJ; Leung SO; Shih LB; Shevitz J; Shukla R; Haraga L; Goldenberg DM; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5978s-5982s. PubMed ID: 7493380
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.
Stein R; Belisle E; Hansen HJ; Goldenberg DM
Cancer Immunol Immunother; 1993 Oct; 37(5):293-8. PubMed ID: 7691407
[TBL] [Abstract][Full Text] [Related]
5. Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation site.
Leung SO; Dion AS; Pellegrini MC; Losman MJ; Grebenau RC; Goldenberg DM; Hansen HJ
Int J Cancer; 1995 Feb; 60(4):534-8. PubMed ID: 7829269
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
7. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
[TBL] [Abstract][Full Text] [Related]
8. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells.
Lundberg BB; Griffiths G; Hansen HJ
J Control Release; 2004 Jan; 94(1):155-61. PubMed ID: 14684279
[TBL] [Abstract][Full Text] [Related]
9. Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
Shih LB; Lu HH; Xuan H; Goldenberg DM
Int J Cancer; 1994 Feb; 56(4):538-45. PubMed ID: 8112889
[TBL] [Abstract][Full Text] [Related]
10. Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.
Juweid M; Sharkey RM; Markowitz A; Behr T; Swayne LC; Dunn R; Hansen HJ; Shevitz J; Leung SO; Rubin AD
Cancer Res; 1995 Dec; 55(23 Suppl):5899s-5907s. PubMed ID: 7493367
[TBL] [Abstract][Full Text] [Related]
11. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
12. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
[TBL] [Abstract][Full Text] [Related]
13. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.
Suzawa T; Nagamura S; Saito H; Ohta S; Hanai N; Kanazawa J; Okabe M; Yamasaki M
J Control Release; 2002 Feb; 79(1-3):229-42. PubMed ID: 11853934
[TBL] [Abstract][Full Text] [Related]
15. Influence of oil droplet surface charge on the performance of antibody--emulsion conjugates.
Goldstein D; Sader O; Benita S
Biomed Pharmacother; 2007 Jan; 61(1):97-103. PubMed ID: 17011740
[TBL] [Abstract][Full Text] [Related]
16. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.
Tseng YL; Hong RL; Tao MH; Chang FH
Int J Cancer; 1999 Mar; 80(5):723-30. PubMed ID: 10048974
[TBL] [Abstract][Full Text] [Related]
17. Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes.
Mukthavaram R; Shi G; Kesari S; Simberg D
J Control Release; 2014 Jun; 183():146-53. PubMed ID: 24685706
[TBL] [Abstract][Full Text] [Related]
18. A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol).
Lundberg BB
J Pharm Pharmacol; 1997 Jan; 49(1):16-21. PubMed ID: 9120763
[TBL] [Abstract][Full Text] [Related]
19. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
Goldenberg DM; Horowitz JA; Sharkey RM; Hall TC; Murthy S; Goldenberg H; Lee RE; Stein R; Siegel JA; Izon DO
J Clin Oncol; 1991 Apr; 9(4):548-64. PubMed ID: 2066752
[TBL] [Abstract][Full Text] [Related]
20. Antibody mediated lung targeting of long-circulating emulsions.
Song YK; Liu D; Maruyama KZ; Takizawa T
PDA J Pharm Sci Technol; 1996; 50(6):372-7. PubMed ID: 9038083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
